A molecular diagnostic professional society has become the second organization to file a lawsuit seeking to block the FDA’s final rule applying the agency’s regulatory requirements for medical devices to laboratory developed tests (LDTs) (Association for Molecular Pathology v. U.S. Food and Drug Administration, No. 3:24-cv-00241 (S.D. Tex.)). In announcing the Aug. 19 filing ... Read More